Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) FCF Margin (2016 - 2020)

Forte Biosciences (FBRX) has disclosed FCF Margin for 5 consecutive years, with 378.97% as the latest value for Q1 2020.

  • On a quarterly basis, FCF Margin rose 19832341.0% to 378.97% in Q1 2020 year-over-year; TTM through Dec 2020 was 2436.9%, a 1058413.0% increase, with the full-year FY2019 number at 8147.22%, down 795512.0% from a year prior.
  • FCF Margin was 378.97% for Q1 2020 at Forte Biosciences, up from 8244.44% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 177700.0% in Q2 2019 to a low of 197944.44% in Q1 2019.
  • A 5-year average of 36033.92% and a median of 2049.49% in 2018 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -14489965bps in 2018, then skyrocketed 30298889bps in 2019.
  • Forte Biosciences' FCF Margin stood at 756.88% in 2016, then plummeted by -11920bps to 89460.0% in 2017, then tumbled by -32bps to 118055.56% in 2018, then skyrocketed by 93bps to 8244.44% in 2019, then surged by 105bps to 378.97% in 2020.
  • Per Business Quant, the three most recent readings for FBRX's FCF Margin are 378.97% (Q1 2020), 8244.44% (Q4 2019), and 4100.0% (Q3 2019).